Twelve vs 24 Months of Dual Antiplatelet Therapy in Patients With Coronary Revascularization for In-stent Restenosis

NCT02402491 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Percutaneous Coronary Intervention

Interventions

DRUG: 12 months of P2Y12 receptor antagonist
DRUG: 24 months of P2Y12 receptor antagonist
DRUG: Aspirin

Sponsor

Beijing Anzhen Hospital